|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:MAP3K4-PACRG (FusionGDB2 ID:51061) |
Fusion Gene Summary for MAP3K4-PACRG |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: MAP3K4-PACRG | Fusion gene ID: 51061 | Hgene | Tgene | Gene symbol | MAP3K4 | PACRG | Gene ID | 4216 | 135138 |
| Gene name | mitogen-activated protein kinase kinase kinase 4 | parkin coregulated | |
| Synonyms | MAPKKK4|MEKK 4|MEKK4|MTK1|PRO0412 | GLUP|HAK005771|PACRG2.1|PARK2CRG | |
| Cytomap | 6q26 | 6q26 | |
| Type of gene | protein-coding | protein-coding | |
| Description | mitogen-activated protein kinase kinase kinase 4MAP three kinase 1MAP/ERK kinase kinase 4MAPK/ERK kinase kinase 4MEK kinase 4SSK2/SSK22 MAP kinase kinase kinase, yeast, homolog ofdJ473J16.1 (mitogen-activated protein kinase kinase kinase 4)predicte | parkin coregulated gene proteinPARK2 co-regulatedPARK2 coregulatedmolecular chaperone/chaperonin-binding proteinparkin co-regulated gene protein | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q9Y6R4 | PACRGL | |
| Ensembl transtripts involved in fusion gene | ENST00000366919, ENST00000392142, ENST00000348824, ENST00000366920, ENST00000446500, | ENST00000337019, ENST00000366889, ENST00000366888, ENST00000542669, | |
| Fusion gene scores | * DoF score | 7 X 4 X 7=196 | 13 X 11 X 13=1859 |
| # samples | 7 | 19 | |
| ** MAII score | log2(7/196*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(19/1859*10)=-3.29045544658853 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: MAP3K4 [Title/Abstract] AND PACRG [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | MAP3K4(161413115)-PACRG(163735859), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | MAP3K4-PACRG seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF. MAP3K4-PACRG seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. MAP3K4-PACRG seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. MAP3K4-PACRG seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. MAP3K4-PACRG seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | MAP3K4 | GO:0000186 | activation of MAPKK activity | 9305639|9827804 |
| Hgene | MAP3K4 | GO:0043507 | positive regulation of JUN kinase activity | 9305639 |
| Hgene | MAP3K4 | GO:1900745 | positive regulation of p38MAPK cascade | 9305639 |
| Fusion gene breakpoints across MAP3K4 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across PACRG (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | COAD | TCGA-AA-3664-01A | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
Top |
Fusion Gene ORF analysis for MAP3K4-PACRG |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000366919 | ENST00000337019 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| In-frame | ENST00000366919 | ENST00000366889 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| Frame-shift | ENST00000366919 | ENST00000366888 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| 5CDS-intron | ENST00000366919 | ENST00000542669 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| Frame-shift | ENST00000392142 | ENST00000337019 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| In-frame | ENST00000392142 | ENST00000366889 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| Frame-shift | ENST00000392142 | ENST00000366888 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| 5CDS-intron | ENST00000392142 | ENST00000542669 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| Frame-shift | ENST00000348824 | ENST00000337019 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| In-frame | ENST00000348824 | ENST00000366889 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| Frame-shift | ENST00000348824 | ENST00000366888 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| 5CDS-intron | ENST00000348824 | ENST00000542669 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| Frame-shift | ENST00000366920 | ENST00000337019 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| In-frame | ENST00000366920 | ENST00000366889 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| Frame-shift | ENST00000366920 | ENST00000366888 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| 5CDS-intron | ENST00000366920 | ENST00000542669 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| intron-3CDS | ENST00000446500 | ENST00000337019 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| intron-3CDS | ENST00000446500 | ENST00000366889 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| intron-3CDS | ENST00000446500 | ENST00000366888 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| intron-intron | ENST00000446500 | ENST00000542669 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000366919 | MAP3K4 | chr6 | 161413115 | + | ENST00000366889 | PACRG | chr6 | 163735859 | + | 1023 | 357 | 218 | 517 | 99 |
| ENST00000392142 | MAP3K4 | chr6 | 161413115 | + | ENST00000366889 | PACRG | chr6 | 163735859 | + | 966 | 300 | 161 | 460 | 99 |
| ENST00000348824 | MAP3K4 | chr6 | 161413115 | + | ENST00000366889 | PACRG | chr6 | 163735859 | + | 936 | 270 | 131 | 430 | 99 |
| ENST00000366920 | MAP3K4 | chr6 | 161413115 | + | ENST00000366889 | PACRG | chr6 | 163735859 | + | 936 | 270 | 131 | 430 | 99 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000366919 | ENST00000366889 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + | 0.31241557 | 0.68758446 |
| ENST00000392142 | ENST00000366889 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + | 0.3705289 | 0.6294711 |
| ENST00000348824 | ENST00000366889 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + | 0.48017493 | 0.51982504 |
| ENST00000366920 | ENST00000366889 | MAP3K4 | chr6 | 161413115 | + | PACRG | chr6 | 163735859 | + | 0.48017493 | 0.51982504 |
Top |
Fusion Genomic Features for MAP3K4-PACRG |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for MAP3K4-PACRG |
| Go to FGviewer for the breakpoints of chr6:161413115-chr6:163735859 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| MAP3K4 | PACRG |
| FUNCTION: Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6. {ECO:0000269|PubMed:12052864, ECO:0000269|PubMed:9305639}. | 248 |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | MAP3K4 | chr6:161413115 | chr6:163735859 | ENST00000366919 | + | 1 | 26 | 25_38 | 50.666666666666664 | 1559.0 | Compositional bias | Note=Poly-Pro |
| Hgene | MAP3K4 | chr6:161413115 | chr6:163735859 | ENST00000366919 | + | 1 | 26 | 4_7 | 50.666666666666664 | 1559.0 | Compositional bias | Note=Poly-Ala |
| Hgene | MAP3K4 | chr6:161413115 | chr6:163735859 | ENST00000392142 | + | 1 | 27 | 25_38 | 50.666666666666664 | 1609.0 | Compositional bias | Note=Poly-Pro |
| Hgene | MAP3K4 | chr6:161413115 | chr6:163735859 | ENST00000392142 | + | 1 | 27 | 4_7 | 50.666666666666664 | 1609.0 | Compositional bias | Note=Poly-Ala |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | MAP3K4 | chr6:161413115 | chr6:163735859 | ENST00000366919 | + | 1 | 26 | 1190_1202 | 50.666666666666664 | 1559.0 | Compositional bias | Note=Poly-Ala |
| Hgene | MAP3K4 | chr6:161413115 | chr6:163735859 | ENST00000392142 | + | 1 | 27 | 1190_1202 | 50.666666666666664 | 1609.0 | Compositional bias | Note=Poly-Ala |
| Hgene | MAP3K4 | chr6:161413115 | chr6:163735859 | ENST00000366919 | + | 1 | 26 | 1343_1601 | 50.666666666666664 | 1559.0 | Domain | Protein kinase |
| Hgene | MAP3K4 | chr6:161413115 | chr6:163735859 | ENST00000392142 | + | 1 | 27 | 1343_1601 | 50.666666666666664 | 1609.0 | Domain | Protein kinase |
| Hgene | MAP3K4 | chr6:161413115 | chr6:163735859 | ENST00000366919 | + | 1 | 26 | 1349_1357 | 50.666666666666664 | 1559.0 | Nucleotide binding | ATP |
| Hgene | MAP3K4 | chr6:161413115 | chr6:163735859 | ENST00000392142 | + | 1 | 27 | 1349_1357 | 50.666666666666664 | 1609.0 | Nucleotide binding | ATP |
Top |
Fusion Gene Sequence for MAP3K4-PACRG |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000366919_ENST00000366889_TCGA-AA-3664-01A_MAP3K4_chr6_161413115_+_PACRG_chr6_163735859_length(transcript)=1023nt_BP=357nt GATCTGGGAGGCTTGTCCCTCGCCGCCCACCGTAGCCCCGGCGCTCGGCCGGTCGCCGTTTCCAAGATGGCCGCGGCGCGCACGGCTCCT GCGGCGGGGTAGAGGCGGAGGCGGAGTCGAGTCACTCCCGCACTTCGGGGCTCCGGTGCCCCGCGCCAGGCTGCAGCTTACTGCCCGCCG CGGCCATGCGGGGCTCCGTGCACGGATGAGAGAAGCCGCTGCCGCGCTGGTCCCTCCTCCCGCCTTTGCCGTCACGCCTGCCGCCGCCAT GGAGGAGCCGCCGCCACCGCCGCCGCCGCCACCACCGCCACCGGAACCCGAGACCGAGTCAGAACCCGAGTGCTGCTTGGCGGCGAGTGA ACTCCGGAGACGGCATTGACTACAGCCAGCAGAAGAGGGAGAACATTGGGGACTTGATCCAGGAGACACTGGAGGCCTTCGAGCGCTACG GAGGAGAAAATGCCTTTATCAACATTAAGTACGTGGTCCCAACCTACGAGTCTTGCTTGCTAAACTAACAGTGGCAGCAGCTGGGACTTG AAACCTCCCGTTGGTGTTGGGATCATCTGTCTCTGTTGCTTTTAGCATCTCATTCCTTGTGACTTCCACAGCTTTCTTTTCTACAGCTGC TAAAATAGTGGCTTATGGGCCATTGGACTGTTAGCCCTATTGAGAGCAAGGCTTTCCAATACATAAATAGTGTCTGTTTCTTAGATTACA ATAGTGTACTGTGCTTATTTGTTCTAAGAGAAGAATTGCTTCTTTATACAGCTCCGACAGAAGCAGGAGTCCGAGTTAAACCTTCAGTTG TATAGACAATAAACTATAATTTTCATATGCAATTCAGCAATTGCTGTTCTGTGTGTGCCTGCCCTGGGGGTGATGTCAGAGGTTGTAAGG GAAGAGTTTATGCTGACTGCTTACTAGGTGTTTGTCATGGAAGAGAAGCATGGGTTCAGCAGTGCCTCTCTAGCAGCTGTGCGGAATAAT >In-frame_ENST00000366919_ENST00000366889_TCGA-AA-3664-01A_MAP3K4_chr6_161413115_+_PACRG_chr6_163735859_length(amino acids)=99AA_start in transcript=218_stop in transcript=517 MPRWSLLPPLPSRLPPPWRSRRHRRRRHHRHRNPRPSQNPSAAWRRVNSGDGIDYSQQKRENIGDLIQETLEAFERYGGENAFINIKYVV -------------------------------------------------------------- >In-frame_ENST00000392142_ENST00000366889_TCGA-AA-3664-01A_MAP3K4_chr6_161413115_+_PACRG_chr6_163735859_length(transcript)=966nt_BP=300nt GTTTCCAAGATGGCCGCGGCGCGCACGGCTCCTGCGGCGGGGTAGAGGCGGAGGCGGAGTCGAGTCACTCCCGCACTTCGGGGCTCCGGT GCCCCGCGCCAGGCTGCAGCTTACTGCCCGCCGCGGCCATGCGGGGCTCCGTGCACGGATGAGAGAAGCCGCTGCCGCGCTGGTCCCTCC TCCCGCCTTTGCCGTCACGCCTGCCGCCGCCATGGAGGAGCCGCCGCCACCGCCGCCGCCGCCACCACCGCCACCGGAACCCGAGACCGA GTCAGAACCCGAGTGCTGCTTGGCGGCGAGTGAACTCCGGAGACGGCATTGACTACAGCCAGCAGAAGAGGGAGAACATTGGGGACTTGA TCCAGGAGACACTGGAGGCCTTCGAGCGCTACGGAGGAGAAAATGCCTTTATCAACATTAAGTACGTGGTCCCAACCTACGAGTCTTGCT TGCTAAACTAACAGTGGCAGCAGCTGGGACTTGAAACCTCCCGTTGGTGTTGGGATCATCTGTCTCTGTTGCTTTTAGCATCTCATTCCT TGTGACTTCCACAGCTTTCTTTTCTACAGCTGCTAAAATAGTGGCTTATGGGCCATTGGACTGTTAGCCCTATTGAGAGCAAGGCTTTCC AATACATAAATAGTGTCTGTTTCTTAGATTACAATAGTGTACTGTGCTTATTTGTTCTAAGAGAAGAATTGCTTCTTTATACAGCTCCGA CAGAAGCAGGAGTCCGAGTTAAACCTTCAGTTGTATAGACAATAAACTATAATTTTCATATGCAATTCAGCAATTGCTGTTCTGTGTGTG CCTGCCCTGGGGGTGATGTCAGAGGTTGTAAGGGAAGAGTTTATGCTGACTGCTTACTAGGTGTTTGTCATGGAAGAGAAGCATGGGTTC >In-frame_ENST00000392142_ENST00000366889_TCGA-AA-3664-01A_MAP3K4_chr6_161413115_+_PACRG_chr6_163735859_length(amino acids)=99AA_start in transcript=161_stop in transcript=460 MPRWSLLPPLPSRLPPPWRSRRHRRRRHHRHRNPRPSQNPSAAWRRVNSGDGIDYSQQKRENIGDLIQETLEAFERYGGENAFINIKYVV -------------------------------------------------------------- >In-frame_ENST00000348824_ENST00000366889_TCGA-AA-3664-01A_MAP3K4_chr6_161413115_+_PACRG_chr6_163735859_length(transcript)=936nt_BP=270nt CCTGCGGCGGGGTAGAGGCGGAGGCGGAGTCGAGTCACTCCCGCACTTCGGGGCTCCGGTGCCCCGCGCCAGGCTGCAGCTTACTGCCCG CCGCGGCCATGCGGGGCTCCGTGCACGGATGAGAGAAGCCGCTGCCGCGCTGGTCCCTCCTCCCGCCTTTGCCGTCACGCCTGCCGCCGC CATGGAGGAGCCGCCGCCACCGCCGCCGCCGCCACCACCGCCACCGGAACCCGAGACCGAGTCAGAACCCGAGTGCTGCTTGGCGGCGAG TGAACTCCGGAGACGGCATTGACTACAGCCAGCAGAAGAGGGAGAACATTGGGGACTTGATCCAGGAGACACTGGAGGCCTTCGAGCGCT ACGGAGGAGAAAATGCCTTTATCAACATTAAGTACGTGGTCCCAACCTACGAGTCTTGCTTGCTAAACTAACAGTGGCAGCAGCTGGGAC TTGAAACCTCCCGTTGGTGTTGGGATCATCTGTCTCTGTTGCTTTTAGCATCTCATTCCTTGTGACTTCCACAGCTTTCTTTTCTACAGC TGCTAAAATAGTGGCTTATGGGCCATTGGACTGTTAGCCCTATTGAGAGCAAGGCTTTCCAATACATAAATAGTGTCTGTTTCTTAGATT ACAATAGTGTACTGTGCTTATTTGTTCTAAGAGAAGAATTGCTTCTTTATACAGCTCCGACAGAAGCAGGAGTCCGAGTTAAACCTTCAG TTGTATAGACAATAAACTATAATTTTCATATGCAATTCAGCAATTGCTGTTCTGTGTGTGCCTGCCCTGGGGGTGATGTCAGAGGTTGTA AGGGAAGAGTTTATGCTGACTGCTTACTAGGTGTTTGTCATGGAAGAGAAGCATGGGTTCAGCAGTGCCTCTCTAGCAGCTGTGCGGAAT >In-frame_ENST00000348824_ENST00000366889_TCGA-AA-3664-01A_MAP3K4_chr6_161413115_+_PACRG_chr6_163735859_length(amino acids)=99AA_start in transcript=131_stop in transcript=430 MPRWSLLPPLPSRLPPPWRSRRHRRRRHHRHRNPRPSQNPSAAWRRVNSGDGIDYSQQKRENIGDLIQETLEAFERYGGENAFINIKYVV -------------------------------------------------------------- >In-frame_ENST00000366920_ENST00000366889_TCGA-AA-3664-01A_MAP3K4_chr6_161413115_+_PACRG_chr6_163735859_length(transcript)=936nt_BP=270nt CCTGCGGCGGGGTAGAGGCGGAGGCGGAGTCGAGTCACTCCCGCACTTCGGGGCTCCGGTGCCCCGCGCCAGGCTGCAGCTTACTGCCCG CCGCGGCCATGCGGGGCTCCGTGCACGGATGAGAGAAGCCGCTGCCGCGCTGGTCCCTCCTCCCGCCTTTGCCGTCACGCCTGCCGCCGC CATGGAGGAGCCGCCGCCACCGCCGCCGCCGCCACCACCGCCACCGGAACCCGAGACCGAGTCAGAACCCGAGTGCTGCTTGGCGGCGAG TGAACTCCGGAGACGGCATTGACTACAGCCAGCAGAAGAGGGAGAACATTGGGGACTTGATCCAGGAGACACTGGAGGCCTTCGAGCGCT ACGGAGGAGAAAATGCCTTTATCAACATTAAGTACGTGGTCCCAACCTACGAGTCTTGCTTGCTAAACTAACAGTGGCAGCAGCTGGGAC TTGAAACCTCCCGTTGGTGTTGGGATCATCTGTCTCTGTTGCTTTTAGCATCTCATTCCTTGTGACTTCCACAGCTTTCTTTTCTACAGC TGCTAAAATAGTGGCTTATGGGCCATTGGACTGTTAGCCCTATTGAGAGCAAGGCTTTCCAATACATAAATAGTGTCTGTTTCTTAGATT ACAATAGTGTACTGTGCTTATTTGTTCTAAGAGAAGAATTGCTTCTTTATACAGCTCCGACAGAAGCAGGAGTCCGAGTTAAACCTTCAG TTGTATAGACAATAAACTATAATTTTCATATGCAATTCAGCAATTGCTGTTCTGTGTGTGCCTGCCCTGGGGGTGATGTCAGAGGTTGTA AGGGAAGAGTTTATGCTGACTGCTTACTAGGTGTTTGTCATGGAAGAGAAGCATGGGTTCAGCAGTGCCTCTCTAGCAGCTGTGCGGAAT >In-frame_ENST00000366920_ENST00000366889_TCGA-AA-3664-01A_MAP3K4_chr6_161413115_+_PACRG_chr6_163735859_length(amino acids)=99AA_start in transcript=131_stop in transcript=430 MPRWSLLPPLPSRLPPPWRSRRHRRRRHHRHRNPRPSQNPSAAWRRVNSGDGIDYSQQKRENIGDLIQETLEAFERYGGENAFINIKYVV -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for MAP3K4-PACRG |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for MAP3K4-PACRG |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | MAP3K4 | Q9Y6R4 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
| Hgene | MAP3K4 | Q9Y6R4 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
| Hgene | MAP3K4 | Q9Y6R4 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
| Hgene | MAP3K4 | Q9Y6R4 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
| Hgene | MAP3K4 | Q9Y6R4 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Top |
Related Diseases for MAP3K4-PACRG |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | MAP3K4 | C0014170 | Endometrial Neoplasms | 1 | CTD_human |
| Hgene | MAP3K4 | C0027708 | Nephroblastoma | 1 | CTD_human |
| Hgene | MAP3K4 | C0476089 | Endometrial Carcinoma | 1 | CTD_human |
| Hgene | MAP3K4 | C2930471 | Bilateral Wilms Tumor | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies